Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 19 of 31

COMPLETED Phase 2

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

NCT02300545
COMPLETED Phase 1

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis

NCT02417688
COMPLETED Phase 1

Communicating Multiple Disease Risks

NCT02621671
COMPLETED NA

Preventing Weight Gain in African American Reproductive-Aged Women

NCT02416921
COMPLETED NA

Pregabalin in CIPN

NCT02394951
COMPLETED NA

Mindfulness-Based Stress Reduction, Health Education and Exercise

NCT02665481
TERMINATED NA

Comparing Ketamine and Morphine in the Treatment of Acute Fracture Pain

NCT02430818
COMPLETED

Study for the Evaluation of a GVHD Negative Outcome Score (GNOS) in Matched Unrelated or Haploidentical Hematopoietic Stem Cell Transplant

NCT02414113
COMPLETED Phase 2

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

NCT02296684
COMPLETED Phase 1

Electromagnetic Navigation for Peripheral Pulmonary Lesions

NCT02582944
COMPLETED NA

Reducing Adenoviral Patient Infected Days

NCT02472223
COMPLETED Early Phase 1

Deconditioning in Transplant

NCT02611219
TERMINATED Phase 1

FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

NCT02371031
COMPLETED NA

Home Hazard Removal Program to Reduce Falls

NCT02392013
COMPLETED Phase 1

Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

NCT02220608
COMPLETED Phase 1

Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas

NCT02181218
COMPLETED Phase 4

Asthma Symptom Based Adjustment of Inhaled Steroid Therapy in African American Children

NCT02298205
COMPLETED

Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS

NCT02686268
COMPLETED NA

Improving Adherence in Renal Dialysis Patients Through Electronic Interventions

NCT02970201
COMPLETED NA

Lidocaine for Diabetic Peripheral Neuropathy

NCT02363803
COMPLETED Phase 1

Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer

NCT02283372
TERMINATED Phase 2

A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation

NCT02112045
COMPLETED NA

Community Participation Transition After Stroke

NCT02396589
TERMINATED NA

Whipple Procedure: Standard of Care vs. Thunderbeat

NCT02204124
COMPLETED

Contraceptive Choice Center

NCT02633631
COMPLETED Phase 1

Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies

NCT02264886
COMPLETED NA

Methadone in Ambulatory Surgery

NCT02300077
COMPLETED NA

Laryngectomy Education

NCT02601638
COMPLETED Early Phase 1

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)

NCT02498379
COMPLETED NA

Comparison of Nasal and Forehead Oximetry in Critically Ill Patients at Risk for Decreased Peripheral Perfusion

NCT02382133
COMPLETED

ED Lung Protective Ventilation to Reduce Complications

NCT02543554
COMPLETED Phase 1

Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT02086604
COMPLETED NA

Diabetic Shoulder Mobility

NCT02162212
TERMINATED NA

Intensive Case Diabetes Management (ICDM) to Prevent Readmission

NCT02230488
COMPLETED Phase 2

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

NCT02098109
TERMINATED Phase 1

Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

NCT01790035
TERMINATED Phase 1

Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

NCT01898793
TERMINATED NA

4D Phase Contrast MR: Hypertrophy in Liver Cancer

NCT02618447
COMPLETED NA

Alvimopan and Ileus in PSF

NCT02218190
COMPLETED NA

Weight Loss-Independent Metabolic Effects of Roux-En-Y Gastric Bypass in Diabetes

NCT02207777
COMPLETED Phase 1

Treatment -Resistant Neovascular Age-Related Macular Degeneration

NCT02332941
COMPLETED NA

Peripheral Sensory Input in Central Post Stroke Pain (CPSP)

NCT02148588
COMPLETED

Falls Risk Questionnaire in Older Adults With Cancer

NCT02204137
COMPLETED Early Phase 1

Photoacoustic Endoscopy of Barrett's Esophagus

NCT02606292
TERMINATED NA

Evaluation of Ureteral Stents in the Management of Stone Disease

NCT02211313
COMPLETED NA

Enhanced Medical Rehabilitation in Older Adults

NCT02114879
TERMINATED Early Phase 1

Tamoxifen to Treat Barrett's Metaplasia

NCT02089386
TERMINATED Phase 2

Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity

NCT02124902
COMPLETED Phase 1

To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery

NCT02204813
COMPLETED Phase 2

Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis

NCT01773967
← Previous Page 19 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

Therapeutic Areas

Obesity 20
Breast Cancer 19
Multiple Myeloma 13
Myelodysplastic Syndromes 13
Alzheimer Disease 10
Parkinson Disease 8
Depression 8
Cancer of the Breast 7
Dementia 7
Insulin Resistance 7

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.